نتایج جستجو برای: dose fdg

تعداد نتایج: 324146  

2011
Linda Mileshkin Rodney J. Hicks Brett G.M. Hughes Paul L.R. Mitchell Veena Charu Barbara J. Gitlitz David Macfarlane Benjamin Solomon Lukas C. Amler Wei Yu Andrea Pirzkall Bernard M. Fine

Purpose: Assessing clinical activity ofmolecularly targeted anticancer agents, especially in the absence of tumor shrinkage, is challenging. To evaluate on-treatment 18F-fluorodeoxyglucose (FDG) and/or 18Ffluorodeoxythymidine (FLT) positron emission tomography (PET) for this purpose, we conducted a prospective multicenter trial assessing PET response rates and associations with progression-free...

2014
Stefan Walbom Harders Hans Henrik Madsen Karin Hjorthaug Anne Kirstine Arveschoug Torben Riis Rasmussen Peter Meldgaard Johanne Andersen Hoejbjerg Hans Kristian Pilegaard Henrik Hager Michael Rehling Finn Rasmussen

BACKGROUND After the diagnosis Non-Small-Cell Lung Carcinoma (NSCLC) has been established, consideration must turn toward the stage of disease, because this will impact directly on management and prognosis. Staging is used to predict survival and to guide the patient toward the most appropriate treatment regimen or clinical trial. Distinguishing malignant involvement of the mediastinal lymph no...

Journal: :Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2015
Hatice Gungor Azeem Saleem Syed Babar Roberto Dina Mona A El-Bahrawy Ed Curry Nona Rama Michele Chen Emily Pickford Roshan Agarwal Sarah Blagden Sabin Carme Cristian Salinas Sam Madison Elizabeth Krachey Ademi Santiago-Walker Deborah A Smith Shannon R Morris Euan A Stronach Hani Gabra

UNLABELLED AKT (a serine/threonine-specific protein kinase) regulates many cellular processes contributing to cytotoxic drug resistance. This study's primary objective examined the relationship between GSK2141795, an oral, pan-AKT inhibitor, and (18)F-FDG PET markers of glucose metabolism in tumor tissue to determine whether (18)F-FDG PET could be used to guide personalized dosing of GSK2141795...

2011
Linda Mileshkin Rodney J. Hicks Brett G.M. Hughes Paul L.R. Mitchell Veena Charu Barbara J. Gitlitz David Macfarlane Benjamin Solomon Lukas C. Amler Wei Yu Andrea Pirzkall Bernard M. Fine

Purpose: Assessing clinical activity ofmolecularly targeted anticancer agents, especially in the absence of tumor shrinkage, is challenging. To evaluate on-treatment 18F-fluorodeoxyglucose (FDG) and/or 18Ffluorodeoxythymidine (FLT) positron emission tomography (PET) for this purpose, we conducted a prospective multicenter trial assessing PET response rates and associations with progression-free...

Journal: :Annals of oncology : official journal of the European Society for Medical Oncology 1997
M de Wit D Bumann W Beyer K Herbst M Clausen D K Hossfeld

BACKGROUND PET using 18fluorodesoxyglucose (FDG) may offer the possibility of differentiating vital from necrotic residual masses. PATIENTS AND METHODS Seventeen patients with HD and 17 patients with NHL underwent FDG-PET following therapy. According to staging by routine methods at diagnosis, 7 patients presented stage I, 13 stage II, 5 stage III, and 9 stage IV. A dose of 250-400 MBq FDG wa...

Journal: :Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2011
Nikolaos D Papathanasiou Mark N Gaze Kevin Sullivan Matthew Aldridge Wendy Waddington Ahmad Almuhaideb Jamshed B Bomanji

UNLABELLED The aim of our study was to evaluate prospectively the diagnostic performance and prognostic significance of (18)F-FDG PET/CT in comparison with (123)I-metaiodobenzylguanidine ((123)I-MIBG) imaging in patients with high-risk neuroblastoma. METHODS Twenty-eight patients with refractory or relapsed high-risk neuroblastoma (16 male and 12 female patients; age range, 2-45 y; median age...

2002
Ying-Ling Sun Meei-Ling Jan Pan-Fu Kao Kuo-Hsien Fan Wen-Chen Chang Te-Wei Lee Gann Ting

Received 1/8/2002; accepted 1/17/2002. For correspondence or reprints contact: Pan-Fu Kao, M.D., Department of Nuclear Medicine, Chang Gung Memorial Hospital and Chang Gung University, 199 Tung Hwa North Road, Taipei 105, Taiwan, R.O.C. Tel: (886)3-3281200 ext. 2622, Fax: (886)3-3282619, E-mail: [email protected] Background: Fluor ine-18-2-deoxy-D-glucose ([F]FDG) has been widespread use...

2017
Gerben R. Borst Katrien De Jaeger Adriaan A. Lammertsma Joos V. Lebesque

The aim of this study was to investigate the relationship between standardized uptake value (SUV), obtained from [18F]fluorodeoxyglucose positron emission tomography (FDG PET), and treatment response and survival of inoperable NSCLC patients treated with high dose radiotherapy. Fifty-one patients were included, recording stage, performance, weight loss, tumour volume, histology, lymph node invo...

Journal: :Onkologie 2005
Carsten Nieder Anca-Ligia Grosu

BACKGROUND Radiotherapy of skin cancer in a previously irradiated area is a challenging task with regard to cumulative total dose and consecutive normal tissue toxicity. Methods of biological response monitoring might be helpful in achieving a favorable therapeutic ratio. PATIENT AND METHODS We report the case of a 77-year-old patient with squamous cell skin carcinoma originating within a pre...

2017
Gerben R. Borst Gerben Borst Gysbert S. Zijlstra Gerben Roelof Borst

The aim of this study was to investigate the relationship between standardized uptake value (SUV), obtained from [18F]fluorodeoxyglucose positron emission tomography (FDG PET), and treatment response and survival of inoperable NSCLC patients treated with high dose radiotherapy. Fifty-one patients were included, recording stage, performance, weight loss, tumour volume, histology, lymph node invo...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید